866-997-4948(US-Canada Toll Free)

Javlor (Bladder Cancer) - Analysis and Forecasts to 2020

Published By :

GlobalData

Published Date : Oct 2011

Category :

Bladder Cancer

No. of Pages : 21 Pages

 

GlobalDatas pharmaceuticals report, Javlor (Bladder Cancer) Analysis and Forecasts to 2020 provides Javlor global sales estimates. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2010-2020). The report also includes information on Bladder Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts.

 

Scope

 

  • Therapy area profile including patient population for the US, EU5 and Japan (seven major markets)
  • Analysis and review of Javlor including sales data
  • Qualitative and quantitative assessment of market space
  • Analysis of the trends, drivers and restraints shaping and defining the markets
  • In-depth analysis of Javlor including efficacy, safety, pricing, competition and other details which influence its sales potential
  • Global sales forecast for 2010-2020 for Javlor

 

Reasons to buy

 

  • Understand and capitalize by identifying products that are most likely to ensure a robust return
  • Stay ahead of competition by understanding the changing competitive landscape
  • Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential
  • Make more informed business decisions from insightful and in-depth analysis of the drugs performance
  • Examine the historical sales performance of a drug in seven major markets
  • Obtain sales forecast for currently marketed/pipeline drug for 2011-2020 for all seven major markets

 

Table of content

1 Table of contents 2
1.1 List of Tables 2
1.2 List of Figures 2

2 Introduction 4
2.1 Bladder Cancer Market 4
2.2 Bladder Cancer Disease 4
2.3 GlobalData Pipeline Report Guidance 7

3 Baldder Cancer Disease: Market Characterization 8
3.1 Bladder Cancer Disease Market 8
3.2 Bladder Cancer Disease Market Forecasts and CAGR 8
3.3 Drivers for the Bladder Cancer Disease Market 8
3.3.1 High Prevalence 9
3.3.2 High Incidence 9
3.3.3 High Survival Rate 10
3.3.4 High lifetime costs 10

4 TNM Classification of bladder cancer 11
4.1 American Urological Association 11

5 Javlor 14
5.1 Introduction 14
5.2 Mechanism of Action 14
5.3 Clinical Studies 14
5.4 Approval History of Javlor 15
5.5 Sales drivers 15
5.5.1 Bladder Cancer Market 15
5.5.2 Targeting the Niche Market 15
5.5.3 Improved Survival 15
5.5.4 Mechanism of Action 15
5.5.5 No Competition 16
5.6 Drug Evaluation 16
5.6.1 Efficacy 16
5.6.2 Safety 16
5.6.3 Compliance 17
5.6.4 Dosing Convenience 17
5.6.5 Competition 17
5.7 Sales forecast 17
5.7.1 Target patient Pool of Javlor 17
5.7.2 Market Penetration 18
5.7.3 Annual Cost of Therapy 19
5.7.4 Sales Projections of Javlor 19

6 Bladder Cancer Market: Appendix 19
6.1 Market Definitions 19
6.2 List of Abberiviations 19
6.3 Research Methodology 19
6.3.1 Coverage 19
6.3.2 Secondary Research 19
6.3.3 Forecasting 20
6.3.4 Number of Patients Approved to take the Drug 20
6.3.5 Net Penetration of Drug 20
6.3.6 Net Annual Dosing 20
6.3.7 Annual Cost of Therapy 21
6.3.8 Primary Research 21
6.3.9 Expert Panels 21
6.4 Contact Us 21
6.5 Disclaimer 21
6.6 Sources 21

 

List of Table


Table 1: Bladder Cancer Incidences & Mortality 5
Table 2: Bladder Cancer, Global, Market Forecast ($bn), 20092020 8
Table 3: Approval History of Javlor 15

List of Chart


Figure 1: Percentage Distribution of Top 20 Diagnosed Cancers 4
Figure 2: Fatality = [(%Distribution of Incidence) (% Distribution Mortality )] of Top 20 Cancers 5
Figure 3: Percentage share of risk factors in Developed Countries 6
Figure 4: Percentage share of risk factors in Developing Countries 6
Figure 5: Smoking Consumption Curve, US (1960-2006) 6
Figure 6: Bladder Cancer, Global, Market Forecasts ($bn), 2009-2020 8
Figure 7: All Cancer Incidence Worldwide 9
Figure 8: Bladder Cancer Incidence Worldwide 9
Figure 9: Broad Classification of Bladder Cancer 11
Figure 10: Classification of NMI Bladder Cancer 11
Figure 11: Detailed TNM Classifications 12
Figure 12: Classification of NMI Bladder Cancer 13
Figure 13: Drug Model Diagram of Javlor 18
Figure 14: Global Forecasted Sales of Javlor ($m) 2010-2020 19
Figure 15: Distribution of Javlor Sales in Major Countries, 2010 20

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *